ASTELLAS PHARMA UNSP.ADR (YPHA) — Free Cash Flow Generation Index
ASTELLAS PHARMA UNSP.ADR (YPHA) has a Free Cash Flow Generation Index of 0.71x as of March 2025. Free cash flow of €137.18 Billion represents 1% of operating cash flow (€194.51 Billion). Explore ASTELLAS PHARMA UNSP.ADR (YPHA) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
ASTELLAS PHARMA UNSP.ADR Free Cash Flow Generation Index (2022–2025)
Historical FCF Generation Index trend for ASTELLAS PHARMA UNSP.ADR across 4 annual periods. For the full cash flow conversion analysis, see ASTELLAS PHARMA UNSP.ADR operating cash flow efficiency.
Annual Free Cash Flow Generation for ASTELLAS PHARMA UNSP.ADR (2022–2025)
Year-by-year Free Cash Flow Generation Index for ASTELLAS PHARMA UNSP.ADR. Check ASTELLAS PHARMA UNSP.ADR investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.71x | €137.18 Billion | €194.51 Billion | €57.33 Billion | ▲ +35.2% |
| 2024 | 0.52x | €89.98 Billion | €172.47 Billion | €82.50 Billion | ▼ -28.5% |
| 2023 | 0.73x | €239.23 Billion | €327.77 Billion | €88.54 Billion | ▲ +3.8% |
| 2022 | 0.70x | €181.00 Billion | €257.44 Billion | €76.45 Billion | — |